Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

74.52

+0.11 (0.15%)

At close: Jun 12, 2026, 4:00 PM EDT

74.51

-0.01 (-0.01%)

After-hours: Jun 12, 2026, 6:35 PM EDT

Arrowhead Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	-188.95	30.11	-609.69	-209.28	-176.49	-140.85
Depreciation & Amortization	25.38	23.93	18.6	12.49	10.42	8.27
Stock-Based Compensation	69.52	63.37	73.97	78.13	120.89	76.67
Other Adjustments	80.7	83.47	27.99	16.31	7.34	-1.44
Change in Receivables	-63.46	-56.97	-	1.41	8.85	-9.41
Changes in Inventories	-0.45	-	-	-	-	-
Changes in Accounts Payable	29.8	6.29	-5.54	33	-6.59	2.63
Changes in Accrued Expenses	-1.99	41.5	32.12	-14.97	17.75	9.52
Changes in Unearned Revenue	113.89	2.4	-0.87	-129.18	-112.5	223.26
Changes in Other Operating Activities	-1.87	-14.54	0.58	58.19	-5.8	2.66
Operating Cash Flow	-36.31	179.55	-462.85	-153.89	-136.13	171.31
Capital Expenditures	-14.57	-22.67	-141.47	-176.74	-52.78	-23.57
Purchases of Investments	-1,180	-796.26	-720.95	-246.14	-223.39	-240.7
Proceeds from Sale of Investments	478.62	689.63	442.34	326.72	270.75	122.59
Investing Cash Flow	-704.02	-129.29	-420.07	-96.16	-5.42	-141.68
Long-Term Debt Issued	353.16	10.26	392	-	-	-
Long-Term Debt Repaid	-134.51	-201.63	-	-	-	-
Net Long-Term Debt Issued (Repaid)	218.66	-191.37	392	-	-	-
Issuance of Common Stock	246.78	270.37	431.65	3.05	5.19	11.31
Net Common Stock Issued (Repurchased)	246.78	270.37	431.65	3.05	5.19	11.31
Other Financing Activities	-70.77	-5	46.87	250	60	-
Financing Cash Flow	741.96	74.01	870.52	253.05	65.19	11.31
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1.17	-0.4	4.2	-0.12	-0.07	-0.09
Net Cash Flow	2.81	123.86	-8.21	2.89	-76.43	40.85
Free Cash Flow	-50.87	156.89	-604.32	-330.63	-188.91	147.75
FCF Margin	-8.18%	18.91%	-17018.30%	-137.34%	-77.67%	106.84%
Free Cash Flow Per Share	-0.37	1.17	-5.05	-3.10	-1.79	1.42
Levered Free Cash Flow	67.94	-156.1	-304.08	-422.48	-325.56	81.92
Unlevered Free Cash Flow	-88.94	94.37	-694.95	-424.97	-331.91	73.73

SEC Filings: 10-K · 10-Q